Multiple Sclerosis Clinical Trial
Next-Gen MS: Feed-forward PRO Data for MS Research
This Next Generation learning health system for Multiple Sclerosis (Next-Gen MS) study is a sub-study of the MS-LINK™ Outcomes Study (NCT04735406). The study aims to examine the effects of using feed forward Patient Reported Outcomes (PROs) data in real-world Multiple Sclerosis (MS) care settings. The study will be conducted within an emerging Learning Healthcare System (LHS).
Participants willing and able to provide written informed consent
Participants with clinical diagnosis of Multiple Sclerosis (MS)
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 8 Locations for this study
Birmingham Alabama, 35209, United States
Washington District of Columbia, 20057, United States
Atlanta Georgia, 30327, United States
Boston Massachusetts, 02215, United States
Owosso Michigan, 48867, United States
Oklahoma City Oklahoma, 73104, United States
Austin Texas, 78759, United States
San Antonio Texas, 78229, United States
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.